Dashboard: Filter Bricks
Main page content
This practical guide reviews the principles of Assertive Community Treatment (ACT), presents key considerations for adapting ACT across various treatment settings, populations, and related domain areas, and provides practical guidance for navigating cross-cutting issues.
This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
The guide provides considerations and strategies for interdisciplinary teams, peer specialists, clinicians, registered nurses, behavioral health organizations, and policy makers in understanding, selecting, and implementing evidence-based interventions that support older adults with serious mental illness.
A guide for community leaders to use when planning to implement the “Talk. They Hear You.” campaign in their communities. The guide offers best practices and step-by-step guidance for using the campaign.
A guide for community leaders to use when planning events on underage drinking and substance use prevention for parents and caregivers, educators, and other adult role models. The guide offers best practices and sample materials for planning successful events.
A guide for community leaders to use when working with the media to promote underage drinking and substance use prevention resources for parents and caregivers, educators, and other adult role models. The guide offers best practices and sample materials for engaging the media.
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Displaying 1 - 10 out of 78